The in vitro results demonstrate that our NPs were adequately sized for tumor targeting, selectively internalized in FR-overexpressing cancer cells, and able to induce apoptosis, activating a caspase 3/7 mechanism without affecting normal cells. The gene discussed is CASP3; the disease is cancer.